INOZYME PHARMA INC. -
5.2400
08-十月-24 11:28:28
15 分钟延时
股票
+0.0200
+0.38%
今日范围
5.2200 - 5.4552
ISIN
N/A
来源
NASDAQ
-
09 6月 2021 06:30:00 条件 Nasdaq GlobeNewswire
-
Inozyme Pharma Reports Q1 2021 Financial Results and Provides Business Highlights
12 5月 2021 05:00:00 条件 Nasdaq GlobeNewswire
-
07 5月 2021 06:30:00 条件 Nasdaq GlobeNewswire
-
Inozyme Pharma to Present at the BofA Securities 2021 Virtual Healthcare Conference
06 5月 2021 06:30:01 条件 Nasdaq GlobeNewswire
-
Inozyme Pharma Publishes Data Supporting INZ-701 as a Potential Treatment for ENPP1 Deficiency
29 4月 2021 06:30:00 条件 Nasdaq GlobeNewswire
-
Inozyme Pharma to Present Burden of Illness Data at the 2021 ACMG Annual Clinical Genetics Meeting
08 4月 2021 06:30:00 条件 Nasdaq GlobeNewswire
-
Inozyme Pharma Expands its Scientific Advisory Board
01 4月 2021 06:30:00 条件 Nasdaq GlobeNewswire
-
Inozyme Pharma Reports Full Year 2020 Financial Results and Provides Business Highlights
25 3月 2021 05:00:00 条件 Nasdaq GlobeNewswire
-
The Balancing Act® on Lifetime to Feature ENPP1 Deficiency
11 3月 2021 06:30:00 条件 Nasdaq GlobeNewswire
-
Inozyme Pharma Appoints Deborah Wenkert, M.D., as Senior Vice President and Chief Medical Officer
04 2月 2021 05:00:00 条件 Nasdaq GlobeNewswire
-
04 1月 2021 05:00:00 条件 Nasdaq GlobeNewswire